[EW] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[EW] Edwards Lifesciences Corporation
Announcement Date
25-Oct-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 13.37%
YoY- 21.60%
Quarter Report
EW's Result
EW's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 1,319,000 1,310,200 1,140,900 1,094,000 906,600 821,500 739,400 10.12%
PBT 407,300 390,900 364,300 301,700 248,700 211,800 185,200 14.03%
Tax 63,800 50,800 39,100 27,000 22,800 41,700 43,800 6.46%
NP 343,500 340,100 325,200 274,700 225,900 170,100 141,400 15.93%
Tax Rate -15.66% -13.00% -10.73% -8.95% -9.17% -19.69% -23.65% -
Total Cost 975,500 970,100 815,700 819,300 680,700 651,400 598,000 8.49%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 26.04 25.96 28.50 25.11 24.92 20.71 19.12 5.28%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS 0.55 0.55 0.52 0.44 0.36 0.27 0.22 16.49%
EPS Diluted 0.55 0.54 0.52 0.43 0.35 0.26 0.22 16.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.